Detalhe da pesquisa
1.
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
Int J Gynecol Cancer
; 31(7): 1075-1079, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226291
2.
Adjuvant treatment for endometrial cancer.
Curr Opin Oncol
; 31(5): 404-410, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31233482
3.
Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
J Obstet Gynaecol Res
; 45(7): 1334-1342, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016845
4.
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
BMC Cancer
; 18(1): 265, 2018 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514593
5.
Prevalence of BRCA1/2 germline mutations in 21â 401 families with breast and ovarian cancer.
J Med Genet
; 53(7): 465-71, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26928436
6.
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).
Gynecol Oncol
; 140(3): 450-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731724
7.
Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Breast Cancer Res Treat
; 152(1): 41-50, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26062751
8.
Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Breast Cancer Res Treat
; 148(2): 269-77, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25292421
9.
Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17ß-estradiol.
BMC Cancer
; 14: 935, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25496649
10.
Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the ago-study group (AGO GYN 5).
Gynecol Oncol
; 133(3): 427-32, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24713545
11.
Kisspeptin-10 inhibits stromal-derived factor 1-induced invasion of human endometrial cancer cells.
Int J Gynecol Cancer
; 24(2): 210-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407584
12.
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).
Int J Gynecol Cancer
; 24(2): 260-5, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24418927
13.
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors.
Int J Gynecol Cancer
; 24(9 Suppl 3): S42-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341579
14.
What is the evidence for lymphadenectomy in presumed early ovarian cancer?
Arch Gynecol Obstet
; 299(1): 1-5, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374648
15.
Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: a study of the Arbeitsgemeinschaft Gynäkologische Onkologie.
Gynecol Oncol
; 129(3): 495-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23500091
16.
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study).
Gynecol Oncol
; 130(2): 289-94, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23694718
17.
Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.
Int J Gynecol Cancer
; 23(1): 34-40, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23154267
18.
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
J Clin Oncol
; 41(4): 893-902, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332161
19.
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
Geburtshilfe Frauenheilkd
; 83(8): 919-962, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37588260
20.
Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
Breast Cancer Res Treat
; 134(1): 199-205, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22290080